Topics:
Thoracic Malignancies • Medical Oncology
Would you consider 160 mg of Osimertinib as opposed to 80 mg for adenocarcinoma lung with leptomeningeal metastasis?
Answer from: Medical Oncologist at Community Practice
I have tried it in 1 patient but it did not work, unfortunately. But there is data to support use 80mg dose as well as 160mg dose. There is an abstract from 2017 ASCO with 160mg dose: BLOOM study abstract or https://clinicaltrials.gov/ct2/show/NCT02228369This is an article with 80mg dose: Standard-d...
Sign in or Register to read more